202610月
CI Oct 2026 · Strong Buy
The Cigna Group ($304.37) presents an asymmetric investment opportunity, trading at an attractive forward multiple against managed care peers. With Fair value assessed at $478.08, Cigna offers 57.1% implied return driven by Evernorth dominant specialty pharmacy volume, resilient commercial self-funded underwriting, and robust annual free cash generation deployed into share buybacks.Latest published research · analyzed 2026-10-22 · current · sources aging